The drug is now approved for treating people with an LVEF of at least 40%, with or without chronic kidney disease.

Improving Global Outcomes (KDIGO) group has updated chronic kidney disease treatment guidelines to help slow disease progression in adults. A JAMA article published Wednesday summarized the revised ...

Patients with heart failure and atrial fibrillation (AF) at the time of mitral transcatheter edge-to-edge repair (M-TEER) for ...

Just over two years into Anderson's tenure, Bayer's board has decided to extend his contract by three years to 31st March, 2029, with company chairman Norbert Winkeljohann saying: "We're starting to ...

Pharmacologic treatment of hypercholesterolemia falls short of U.S. and European guidelines, according to a study published online June 30 in the Journal of General Internal Medicine. G. Caleb ...

New research from Virginia Tech has revealed why certain heart rhythm medications, like flecainide, can become risky when blood sodium levels drop. These drugs are commonly used to treat atrial ...